Gallantt Ispat Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 9:54 pm

Market Cap	12,824 Cr.
Current Price	531
High / Low	545/287
Stock P/E	32.0
Book Value	118
Dividend Yield	0.19 %
ROCE	19.2 %
ROE	15.1 %
Face Value	10.0
PEG Ratio	-17.88

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Gallantt Ispat Ltd

Competitors of Gallantt Ispat Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Chennai Ferrous Industries Ltd	41.8 Cr.	116	175/100	10.4	144	0.00 %	11.1 %	8.01 %	10.0
Bihar Sponge Iron Ltd	145 Cr.	16.1	26.8/10.2	14.0	5.03	0.00 %	45.9 %	%	10.0
Ashirwad Steels & Industries Ltd	41.4 Cr.	33.1	53.0/28.3	18.0	66.5	0.00 %	3.82 %	2.81 %	10.0
Vaswani Industries Ltd	143 Cr.	45.9	73.9/32.0	13.1	43.9	0.00 %	11.0 %	8.42 %	10.0
Sarda Energy & Minerals Ltd	15,553 Cr.	440	566/229	22.2	178	0.23 %	15.6 %	13.8 %	1.00
Industry Average	16,618.56 Cr	270.67		18.62	105.55	0.10%	19.77%	11.98%	7.08

All Competitor Stocks of Gallantt Ispat Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	863	1,021	931	1,006	1,094	1,036	950	1,063	1,177	1,160	943	1,118	1,072
Expenses	753	949	853	921	970	966	863	956	994	945	845	919	889
Operating Profit	110	72	78	86	124	71	86	107	184	215	98	199	183
OPM %	13%	7%	8%	8%	11%	7%	9%	10%	16%	19%	10%	18%	17%
Other Income	44	1	4	1	1	1	2	1	3	1	2	1	12
Interest	6	4	7	8	9	6	7	8	8	6	5	5	5
Depreciation	23	25	25	25	25	25	28	29	34	30	30	29	31
Profit before tax	125	45	50	53	92	41	54	71	145	179	65	165	159
Tax %	29%	45%	45%	61%	26%	25%	13%	26%	34%	32%	25%	31%	27%
Net Profit	89	25	28	21	68	31	47	52	95	122	49	114	116
EPS in Rs	10.93	1.02	1.14	0.87	2.81	1.27	1.96	2.15	3.95	5.05	2.03	4.71	4.82

Last Updated: May 31, 2025, 9:13 am

Below is a detailed analysis of the quarterly data for Gallantt Ispat Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 1,072.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,118.00 Cr. (Dec 2024) to 1,072.00 Cr., marking a decrease of 46.00 Cr..
For Expenses, as of Mar 2025, the value is 889.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 919.00 Cr. (Dec 2024) to 889.00 Cr., marking a decrease of 30.00 Cr..
For Operating Profit, as of Mar 2025, the value is 183.00 Cr.. The value appears to be declining and may need further review. It has decreased from 199.00 Cr. (Dec 2024) to 183.00 Cr., marking a decrease of 16.00 Cr..
For OPM %, as of Mar 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Dec 2024) to 17.00%, marking a decrease of 1.00%.
For Other Income, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 12.00 Cr., marking an increase of 11.00 Cr..
For Interest, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
For Depreciation, as of Mar 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Dec 2024) to 31.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is 159.00 Cr.. The value appears to be declining and may need further review. It has decreased from 165.00 Cr. (Dec 2024) to 159.00 Cr., marking a decrease of 6.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 31.00% (Dec 2024) to 27.00%, marking a decrease of 4.00%.
For Net Profit, as of Mar 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Dec 2024) to 116.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 4.82. The value appears strong and on an upward trend. It has increased from 4.71 (Dec 2024) to 4.82, marking an increase of 0.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:31 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	669	720	670	616	824	1,064	865	2,105	3,017	4,057	4,227	4,293
Expenses	625	656	604	565	738	938	833	1,836	2,721	3,693	3,779	3,598
Operating Profit	44	65	66	52	86	125	32	269	297	364	448	694
OPM %	7%	9%	10%	8%	10%	12%	4%	13%	10%	9%	11%	16%
Other Income	1	1	3	1	5	5	1	9	53	3	7	16
Interest	12	12	7	6	7	6	6	22	20	27	28	22
Depreciation	17	17	18	17	15	14	14	68	92	100	116	120
Profit before tax	16	37	44	30	69	110	13	189	237	240	311	568
Tax %	6%	8%	5%	11%	29%	35%	42%	22%	26%	41%	28%	29%
Net Profit	15	34	42	27	49	72	7	148	176	141	225	401
EPS in Rs	1.85	4.17	5.11	3.28	6.07	8.81	0.92	18.18	21.62	5.84	9.34	16.61
Dividend Payout %	0%	0%	0%	0%	4%	3%	0%	0%	0%	0%	11%	8%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	126.67%	23.53%	-35.71%	81.48%	46.94%	-90.28%	2014.29%	18.92%	-19.89%	59.57%	78.22%
Change in YoY Net Profit Growth (%)	0.00%	-103.14%	-59.24%	117.20%	-34.54%	-137.22%	2104.56%	-1995.37%	-38.81%	79.46%	18.65%

Gallantt Ispat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	20%
5 Years:	38%
3 Years:	12%
TTM:	2%

Compounded Profit Growth
10 Years:	28%
5 Years:	122%
3 Years:	33%
TTM:	78%

Stock Price CAGR
10 Years:	37%
5 Years:	73%
3 Years:	101%
1 Year:	51%

Return on Equity
10 Years:	10%
5 Years:	10%
3 Years:	11%
Last Year:	15%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:08 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	81	81	81	81	81	81	81	81	81	241	241	241
Reserves	166	200	242	282	331	400	405	1,824	2,002	1,984	2,209	2,601
Borrowings	128	91	62	74	55	51	123	388	387	538	462	378
Other Liabilities	60	52	59	31	94	31	54	147	219	186	223	328
Total Liabilities	435	424	444	468	561	564	663	2,441	2,689	2,949	3,136	3,548
Fixed Assets	207	212	205	230	219	208	198	1,348	1,452	1,623	1,894	1,807
CWIP	7	5	18	13	29	127	241	277	359	316	122	318
Investments	43	43	43	43	43	43	43	60	1	2	52	40
Other Assets	179	165	178	183	270	186	182	756	877	1,009	1,068	1,383
Total Assets	435	424	444	468	561	564	663	2,441	2,689	2,949	3,136	3,548

Below is a detailed analysis of the balance sheet data for Gallantt Ispat Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 241.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 241.00 Cr..
For Reserves, as of Mar 2025, the value is 2,601.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,209.00 Cr. (Mar 2024) to 2,601.00 Cr., marking an increase of 392.00 Cr..
For Borrowings, as of Mar 2025, the value is 378.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 462.00 Cr. (Mar 2024) to 378.00 Cr., marking a decrease of 84.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 223.00 Cr. (Mar 2024) to 328.00 Cr., marking an increase of 105.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 3,548.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,136.00 Cr. (Mar 2024) to 3,548.00 Cr., marking an increase of 412.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 1,807.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,894.00 Cr. (Mar 2024) to 1,807.00 Cr., marking a decrease of 87.00 Cr..
For CWIP, as of Mar 2025, the value is 318.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 318.00 Cr., marking an increase of 196.00 Cr..
For Investments, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 12.00 Cr..
For Other Assets, as of Mar 2025, the value is 1,383.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,068.00 Cr. (Mar 2024) to 1,383.00 Cr., marking an increase of 315.00 Cr..
For Total Assets, as of Mar 2025, the value is 3,548.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,136.00 Cr. (Mar 2024) to 3,548.00 Cr., marking an increase of 412.00 Cr..

Notably, the Reserves (2,601.00 Cr.) exceed the Borrowings (378.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	-43	70	56	31	109	43	41	173	234	96	344	579
Cash from Investing Activity +	-27	-20	-22	-40	-83	-37	-106	-193	-209	-225	-248	-460
Cash from Financing Activity +	57	-48	-36	7	-24	-9	65	10	-19	126	-102	-114
Net Cash Flow	-13	2	-1	-2	2	-3	-0	-10	6	-3	-5	5

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-84.00	-26.00	4.00	-22.00	31.00	74.00	-91.00	-119.00	-90.00	-174.00	-14.00	316.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	16	23	12	17	20	22	13	10	23	19	12	9
Inventory Days	53	56	55	57	77	65	51	69	56	50	48	48
Days Payable	50	6	0	3	17	47	8	19	18	24	7	6
Cash Conversion Cycle	20	74	67	71	80	41	55	59	61	45	53	51
Working Capital Days	21	65	66	76	74	63	45	35	105	80	79	80
ROCE %	14%	9%	13%	13%	9%	17%	23%	3%	15%	10%	10%	12%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	67.24%	68.72%	68.72%	68.73%	68.75%	68.79%	68.94%	68.94%	68.93%	68.93%	68.93%	68.93%
FIIs	0.10%	0.03%	0.01%	0.01%	0.01%	0.01%	0.00%	0.01%	0.02%	0.16%	0.09%	0.07%
Public	32.67%	31.25%	31.26%	31.25%	31.22%	31.19%	31.05%	31.04%	31.02%	30.89%	30.96%	30.97%
No. of Shareholders	11,438	18,982	18,346	18,578	18,355	18,876	20,356	20,731	20,884	19,536	18,980	18,286

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 21	Mar 20	Mar 19
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	9.34	5.84	10.01	2.76	12.83
Diluted EPS (Rs.)	9.34	5.84	10.01	2.76	12.83
Cash EPS (Rs.)	14.13	9.99	8.91	2.66	10.54
Book Value[Excl.RevalReserv]/Share (Rs.)	101.57	92.22	90.62	80.55	78.09
Book Value[Incl.RevalReserv]/Share (Rs.)	101.57	92.22	90.62	80.55	78.09
Revenue From Operations / Share (Rs.)	175.19	168.13	123.83	106.37	130.81
PBDIT / Share (Rs.)	18.86	15.23	13.94	4.11	15.99
PBIT / Share (Rs.)	14.07	11.07	12.01	2.37	14.26
PBT / Share (Rs.)	12.90	9.94	10.82	1.59	13.53
Net Profit / Share (Rs.)	9.34	5.84	6.98	0.92	8.81
NP After MI And SOA / Share (Rs.)	9.34	5.84	10.01	2.75	12.83
PBDIT Margin (%)	10.76	9.05	11.25	3.86	12.22
PBIT Margin (%)	8.03	6.58	9.70	2.22	10.90
PBT Margin (%)	7.36	5.91	8.73	1.49	10.33
Net Profit Margin (%)	5.33	3.47	5.63	0.86	6.73
NP After MI And SOA Margin (%)	5.33	3.47	8.08	2.59	9.80
Return on Networth / Equity (%)	9.19	6.33	11.04	3.42	16.42
Return on Capital Employeed (%)	12.71	11.07	12.89	2.68	18.24
Return On Assets (%)	7.18	4.77	8.75	2.69	14.54
Long Term Debt / Equity (X)	0.04	0.04	0.00	0.08	0.00
Total Debt / Equity (X)	0.18	0.24	0.15	0.14	0.08
Asset Turnover Ratio (%)	1.39	0.00	1.28	1.25	1.71
Current Ratio (X)	2.33	1.85	1.22	1.43	2.00
Quick Ratio (X)	1.39	1.04	0.42	0.28	0.64
Inventory Turnover Ratio (X)	7.43	0.00	5.50	5.90	7.18
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	9.07	1.94
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	5.56	1.71
Earning Retention Ratio (%)	0.00	0.00	0.00	90.93	98.06
Cash Earning Retention Ratio (%)	0.00	0.00	0.00	94.44	98.29
Interest Coverage Ratio (X)	16.13	13.49	11.67	5.24	21.72
Interest Coverage Ratio (Post Tax) (X)	8.99	6.18	6.85	2.17	12.96
Enterprise Value (Cr.)	5094.26	1882.18	460.95	246.58	451.73
EV / Net Operating Revenue (X)	1.21	0.46	0.45	0.28	0.42
EV / EBITDA (X)	11.19	5.12	4.07	7.38	3.47
MarketCap / Net Operating Revenue (X)	1.10	0.33	0.35	0.18	0.38
Retention Ratios (%)	0.00	0.00	0.00	90.92	98.05
Price / BV (X)	1.90	0.60	0.48	0.23	0.63
Price / Net Operating Revenue (X)	1.10	0.33	0.35	0.18	0.38
EarningsYield	0.04	0.10	0.22	0.14	0.25

After reviewing the key financial ratios for Gallantt Ispat Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 9.34. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.34, marking an increase of 3.50.
For Diluted EPS (Rs.), as of Mar 24, the value is 9.34. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.34, marking an increase of 3.50.
For Cash EPS (Rs.), as of Mar 24, the value is 14.13. This value is within the healthy range. It has increased from 9.99 (Mar 23) to 14.13, marking an increase of 4.14.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.57. It has increased from 92.22 (Mar 23) to 101.57, marking an increase of 9.35.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.57. It has increased from 92.22 (Mar 23) to 101.57, marking an increase of 9.35.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 175.19. It has increased from 168.13 (Mar 23) to 175.19, marking an increase of 7.06.
For PBDIT / Share (Rs.), as of Mar 24, the value is 18.86. This value is within the healthy range. It has increased from 15.23 (Mar 23) to 18.86, marking an increase of 3.63.
For PBIT / Share (Rs.), as of Mar 24, the value is 14.07. This value is within the healthy range. It has increased from 11.07 (Mar 23) to 14.07, marking an increase of 3.00.
For PBT / Share (Rs.), as of Mar 24, the value is 12.90. This value is within the healthy range. It has increased from 9.94 (Mar 23) to 12.90, marking an increase of 2.96.
For Net Profit / Share (Rs.), as of Mar 24, the value is 9.34. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.34, marking an increase of 3.50.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.34. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.34, marking an increase of 3.50.
For PBDIT Margin (%), as of Mar 24, the value is 10.76. This value is within the healthy range. It has increased from 9.05 (Mar 23) to 10.76, marking an increase of 1.71.
For PBIT Margin (%), as of Mar 24, the value is 8.03. This value is below the healthy minimum of 10. It has increased from 6.58 (Mar 23) to 8.03, marking an increase of 1.45.
For PBT Margin (%), as of Mar 24, the value is 7.36. This value is below the healthy minimum of 10. It has increased from 5.91 (Mar 23) to 7.36, marking an increase of 1.45.
For Net Profit Margin (%), as of Mar 24, the value is 5.33. This value is within the healthy range. It has increased from 3.47 (Mar 23) to 5.33, marking an increase of 1.86.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.33. This value is below the healthy minimum of 8. It has increased from 3.47 (Mar 23) to 5.33, marking an increase of 1.86.
For Return on Networth / Equity (%), as of Mar 24, the value is 9.19. This value is below the healthy minimum of 15. It has increased from 6.33 (Mar 23) to 9.19, marking an increase of 2.86.
For Return on Capital Employeed (%), as of Mar 24, the value is 12.71. This value is within the healthy range. It has increased from 11.07 (Mar 23) to 12.71, marking an increase of 1.64.
For Return On Assets (%), as of Mar 24, the value is 7.18. This value is within the healthy range. It has increased from 4.77 (Mar 23) to 7.18, marking an increase of 2.41.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.04.
For Total Debt / Equity (X), as of Mar 24, the value is 0.18. This value is within the healthy range. It has decreased from 0.24 (Mar 23) to 0.18, marking a decrease of 0.06.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.39. It has increased from 0.00 (Mar 23) to 1.39, marking an increase of 1.39.
For Current Ratio (X), as of Mar 24, the value is 2.33. This value is within the healthy range. It has increased from 1.85 (Mar 23) to 2.33, marking an increase of 0.48.
For Quick Ratio (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 1.39, marking an increase of 0.35.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 7.43. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 7.43, marking an increase of 7.43.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 24, the value is 16.13. This value is within the healthy range. It has increased from 13.49 (Mar 23) to 16.13, marking an increase of 2.64.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.99. This value is within the healthy range. It has increased from 6.18 (Mar 23) to 8.99, marking an increase of 2.81.
For Enterprise Value (Cr.), as of Mar 24, the value is 5,094.26. It has increased from 1,882.18 (Mar 23) to 5,094.26, marking an increase of 3,212.08.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.21. This value is within the healthy range. It has increased from 0.46 (Mar 23) to 1.21, marking an increase of 0.75.
For EV / EBITDA (X), as of Mar 24, the value is 11.19. This value is within the healthy range. It has increased from 5.12 (Mar 23) to 11.19, marking an increase of 6.07.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.10. This value is within the healthy range. It has increased from 0.33 (Mar 23) to 1.10, marking an increase of 0.77.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Price / BV (X), as of Mar 24, the value is 1.90. This value is within the healthy range. It has increased from 0.60 (Mar 23) to 1.90, marking an increase of 1.30.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.10. This value is within the healthy range. It has increased from 0.33 (Mar 23) to 1.10, marking an increase of 0.77.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.04, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gallantt Ispat Ltd as of June 25, 2025 is: 457.01

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 25, 2025, Gallantt Ispat Ltd is Overvalued by 13.93% compared to the current share price 531.00

Intrinsic Value of Gallantt Ispat Ltd as of June 25, 2025 is: 448.83

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 25, 2025, Gallantt Ispat Ltd is Overvalued by 15.47% compared to the current share price 531.00

Last 5 Year EPS CAGR: -1.79%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (1,053.83 cr) compared to borrowings (228.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (365.17 cr) and profit (155.33 cr) over the years.	The stock has a low average ROCE of 12.33%, which may not be favorable. The stock has a high average Working Capital Days of 65.75, which may not be favorable. The stock has a high average Cash Conversion Cycle of 56.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gallantt Ispat Ltd:
1. Net Profit Margin: 5.33%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 12.71% (Industry Average ROCE: 18.12%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.19% (Industry Average ROE: 8.98%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 8.99
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.39
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 32 (Industry average Stock P/E: 13.97)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.18
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Gallantt Ispat Ltd. is a Public Limited Listed company incorporated on 07/02/2005 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L27109UP2005PLC195660 and registration number is 195660. Currently Company is involved in the business activities of Manufacture of basic iron and steel. Company's Total Operating Revenue is Rs. 4292.73 Cr. and Equity Capital is Rs. 241.28 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Steel - Sponge Iron	Gorakhpur Industrial Development Authority (GIDA), Sahjanwa, Gorakhpur Uttar Pradesh 273209	csgml@gallantt.com https://www.gallantt.com

Management
Name	Position Held
Mr. Chandra Prakash Agrawal	Chairman & Managing Director
Mr. Dinesh R Agarwal	Whole Time Director
Mr. Prem Prakash Agrawal	Whole Time Director
Mr. Nitin Mahavir Prasad Kandoi	Whole Time Director
Mr. Prashant Jalan	Director
Mr. Ashtbhuja Prasad Srivastava	Ind. Non-Executive Director
Mr. Udit Agarwal	Ind. Non-Executive Director
Mr. Nishi Agrawal	Ind. Non-Executive Director
Mrs. Smita Modi	Ind. Non-Executive Director
Mr. Pankaj Khanna	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Gallantt Ispat Ltd?

Gallantt Ispat Ltd's intrinsic value (as of 25 June 2025) is ₹457.01 — 13.93% lower the current market price of 531.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12,824 Cr. market cap, FY2025-2026 high/low of ₹545/287, reserves of 2,601 Cr, and liabilities of 3,548 Cr.

What is the Market Cap of Gallantt Ispat Ltd?

The Market Cap of Gallantt Ispat Ltd is 12,824 Cr..

What is the current Stock Price of Gallantt Ispat Ltd as on 25 June 2025?

The current stock price of Gallantt Ispat Ltd as on 25 June 2025 is 531.

What is the High / Low of Gallantt Ispat Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Gallantt Ispat Ltd stocks is ₹545/287.

What is the Stock P/E of Gallantt Ispat Ltd?

The Stock P/E of Gallantt Ispat Ltd is 32.0.

What is the Book Value of Gallantt Ispat Ltd?

The Book Value of Gallantt Ispat Ltd is 118.

What is the Dividend Yield of Gallantt Ispat Ltd?

The Dividend Yield of Gallantt Ispat Ltd is 0.19 %.

What is the ROCE of Gallantt Ispat Ltd?

The ROCE of Gallantt Ispat Ltd is 19.2 %.

What is the ROE of Gallantt Ispat Ltd?

The ROE of Gallantt Ispat Ltd is 15.1 %.

What is the Face Value of Gallantt Ispat Ltd?

The Face Value of Gallantt Ispat Ltd is 10.0.